CTI BIOPHARMA CORP

CUSIP: 12648L601 Class: Common Stock

Ensign Peak Advisors, Inc's Holding History (CIK: 0001454984)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 1,326,062 Value ($000) $5,569 Avg Close — Range —
Q4 2022
Shares 1,326,062 Value ($000) $7,970 Avg Close — Range —
Q3 2022
Shares 706,277 Value ($000) $4,111 Avg Close — Range —
Q2 2022
Shares 149,091 Value ($000) $890 Avg Close — Range —